Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Good Start Genetics gets $14mm through its Series B venture round

Executive Summary

Good Start Genetics Inc. (molecular diagnostics) has raised $14mm through its Series B venture round. Current shareholders OrbiMed Advisors, Safeguard Scientifics, and SV Life Sciences led. The company will use some of the proceeds for commercial activities for its preconception carrier screening tests for cystic fibrosis, Gaucher’s disease, and sickle cell anemia.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies